RecruitingOBSERVATIONAL

Quality of Care in French HIV Infected Patients

This ongoing study, called "Dataids," is collecting important health information from over 30,000 HIV-positive adults in France. Researchers want to understand how HIV changes over time and how different treatments are working for patients, including those for other infections like hepatitis C. By regularly collecting details about patients' health, doctors can see trends and improve the quality of care for people living with HIV. It helps them learn more about the illness and how best to manage it. This information is gathered from routine clinic visits, meaning patients don't need extra appointments just for the study.

At a glance

Status

Recruiting

Sponsor

DatAids

Enrolment target

30,000

Start

01 Jan 2016

Estimated completion

01 Jan 2030

HIV

What is this study about?

Imagine helping doctors understand HIV better, not just for today, but for years to come. That’s exactly what the "Dataids" study aims to do. It’s a very important study happening across 15 different clinics in France, gathering health information from thousands of adults living with HIV. The main goal is to carefully watch how HIV affects people over many years and see how current treatments are working.

Researchers are collecting details about patients' general health, their immune system responses, and how the virus is behaving. They're also looking at other infections people with HIV might have, like hepatitis B or C. By putting all this information together, they can spot important changes over time. This helps them understand if new treatments are making a real difference and how best to care for people living with HIV in France and beyond. It’s all about improving the quality of care.

This study is continuing work that started in 2010. It’s about building a big picture of HIV by learning from real patient experiences during their regular check-ups. The findings from this kind of research are crucial because they directly inform healthcare professionals about the best ways to support and treat people with HIV, leading to better health outcomes for many.

Key takeaways

This study helps improve HIV care in France.
It collects data from routine clinic visits, meaning no extra appointments for you.
It's for adults (18+) living with HIV-1, regardless of their current health status or treatment.
The study watches how HIV and treatments change over many years.
Your health information helps thousands of patients in the future.

Who may be eligible?

This study is looking for adults who are living with HIV-1.

To be part of the study, you must be 18 years old or older. You also need to agree in writing to take part. This is called 'informed consent,' and it means you fully understand what the study is about and agree to share your information.

Importantly, your current health status, such as your immune cell count (CD4), the amount of virus in your blood (viral load), or whether you are taking HIV medication (ART), does not prevent you from joining. This study wants to learn from a wide range of experiences.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Do you have HIV-1?
Are you able to provide written agreement to join the study?
Do you attend one of the 15 participating HIV clinics in France?

Answer every question to see your result.

What does participation involve?

If you are eligible and agree to take part in this study, you won't have any extra appointments beyond your usual HIV clinic visits. The study collects information directly from your routine medical records during these regular check-ups. This includes details like your demographic information (age, gender), immune system information, how the virus is doing, results for other infections like hepatitis, laboratory test results, details about your medications, and any other health information normally collected during your care. This information is collected once a year as part of your ongoing care. There are no new medications or experimental treatments involved, as this is an observational study looking at standard care. You can decide to stop participating at any time.

Potential risks and benefits

There are no known direct medical risks from participating in this study as it involves collecting information from your routine care, not new treatments or extra procedures. Your personal information will be kept confidential to protect your privacy. The main benefit is that the information gathered will help doctors and researchers understand HIV better, improve care, and develop better strategies for managing the condition for all patients in the future. You have the right to withdraw from the study at any time, without it affecting your medical care.

Locations (39)

Hôpital Nord Franche Comté
Verified postcode
Belfort, France· Recruiting
CHU Besançon - Hôpital Jean Minjoz
Verified postcode
Besançon, France· Recruiting
CHRU Brest
Verified postcode
Brest, France· Recruiting
Centre Hospitalier de Brive
Verified postcode
Brive-la-Gaillarde, France· Recruiting
CHU Clermont-Ferrand - Hôpital Gabriel-Montpied
Verified postcode
Clermont-Ferrand, France· Recruiting
CHIC
Verified postcode
Créteil, France· Recruiting
—
Verified postcode
Faye-l'Abbesse, France· Recruiting
CHD Vendée
Verified postcode
La Roche-sur-Yon, France· Recruiting
Centre Hospitalier de La Rochelle
Verified postcode
La Rochelle, France· Recruiting
Hôpital Bicêtre - Assistance Publique des Hôpitaux de Paris
Verified postcode
Le Kremlin-Bicêtre, France· Recruiting
CHU Limoges
Verified postcode
Limoges, France· Recruiting
Hôpital de la Croix-Rousse - Hospices Civils de Lyon
Verified postcode
Lyon, France· Recruiting

Common questions

What is the main goal of this study?

The main goal is to understand how HIV changes over time in France and to see how well current treatments are working for patients.

Do I need extra appointments if I join?

No, you don't need any extra appointments. The study collects information from your regular HIV clinic visits.

Is this study giving new medicines?

No, this study is 'observational,' meaning it just collects information about your standard care and current treatments; no new medicines are given.

Who can join this study?

Adults aged 18 or over, who are living with HIV-1 and agree to participate, can join. Your current health status doesn't stop you.

What happens with my personal information?

Your personal health information will be collected but kept confidential to protect your privacy.

How to find out more

Pascal Pugliese, MD

pugliese.p@chu-nice.fr 0033492035802 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.